Stability of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) <scp>RNA</scp> levels among interferon‐naïve <scp>HIV</scp>/<scp>HCV</scp>‐coinfected individuals treated with combination antiretroviral therapy
Daniel Grint(London School of Hygiene & Tropical Medicine), Brygida Knysz(Wroclaw Medical University), Vincent Soriano(Fundación Instituto Valenciano de Oncología), Adriano Lazzarin(Vita-Salute San Raffaele University), Ole Kirk(University of Copenhagen), O. Suetnov(University of Copenhagen), Joanne Reekie(University of Copenhagen), Amanda Mocroft(University of Copenhagen), Lars Peters(University of Copenhagen), Bruno Ledergerber(University Hospital of Zurich), JK Rockstroh(University of Bonn)
Cited by 16
Related Papers
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
One Biocatalyst–Many Applications: The Use of Candida Antarctica B-Lipase in Organic Synthesis
|Biocatalysis and Biotransformation|1998|682